Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

New treatments for hair loss are being developed.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

The internship highlighted the pharmacist's important role in health education and community engagement.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Changing hair follicle identity could potentially reverse balding.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

Early diagnosis and treatment can help manage hair loss effectively.

A new method using fat tissue cells may help treat hair loss.

Lower SOD enzyme levels are linked to more severe hair loss in men.

Hair loss, known as androgenetic alopecia, is mainly caused by genetics, but also by hormone imbalances, shrinking hair follicles, inflammation, and environmental factors.

Artemis dysfunction might cause hair loss through telomere shortening.

Hair shaft miniaturization leads to hair follicle stem cell loss, suggesting Piezo1 as a potential treatment target.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Scalp biopsies are essential for accurately diagnosing alopecia areata.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

Androgenetic alopecia may be irreversible due to the detachment of a muscle from hair follicles.

Male pattern baldness involves three mechanisms and finasteride can help reverse it.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Citrullus colocynthis fruit extract may effectively treat testosterone-related hair loss, similar to finasteride.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Some cancer treatments can cause permanent hair loss.

Apoptosis may contribute to hair loss in androgenetic alopecia.